GENEVA, Sept. 24 -- KYMAB LIMITED filed a patent application (EP2026/057739) for “ANTI-OX-40 LIGAND (OX40L) ANTIBODY FOR THE TREATMENT OF ASTHMA”. With publication no. WO/2026/195782, here are the other details related to the patent application:
Kind: Initial Publication with ISR [A1]
IPC: C07K 16/28
Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).
Disclaimer: Curated by HT Syndication....